Table 1.
Therapeutic areas and diseases/disorders represented
| n = 174 trials | |
|---|---|
| Central Nervous System/Psychiatric | 48 (28%) |
| Attention deficit hyperactivity disorder | |
| Psychiatric disorders | |
| Epilepsy | |
| Migraine headaches | |
| Neurogenic bladder | |
| Other | |
| Infectious Disease | 42 (24%) |
| HIV | |
| Hepatitis B | |
| Pneumonia | |
| Malaria | |
| Otitis media | |
| Tinea | |
| Other | |
| Cardiovascular | 29 (17%) |
| Arrhythmia | |
| Heart failure | |
| Hypertension | |
| Hyperlipidemia | |
| Other | |
| Allergy/Immunology | 20 (11%) |
| Allergic rhinitis | |
| Asthma | |
| Atopic dermatitis | |
| Juvenile rheumatoid arthritis | |
| Cancer | 11 (6%) |
| Refractory solid tumors | |
| Leukemia/lymphoma | |
| Stem cell transplant | |
| Nausea/vomiting associated with chemotherapy | |
| Endocrine | 10 (6%) |
| Diabetes | |
| Gynecomastia | |
| Obesity | |
| Other | |
| Gastrointestinal | 8 (5%) |
| Gastroesophageal reflux/esophagitis | |
| Anesthesia/Pain Management | 2 (1%) |
| Other | 4 (2%) |